Changes in Heart Proteoglycan Expression and Diastolic Dysfunction in Diabetic Rats
Author Information
Author(s): Célia MC Strunz, Monique Matsuda, Vera MC Salemi, Adriana Nogueira, Antonio P Mansur, Ismar N Cestari, Monica V Marquezini
Primary Institution: Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil
Hypothesis
The study investigates whether alterations in myocardial function during hyperglycemia by insulin depletion are accompanied by changes in the expression of heparan sulfate proteoglycans in cardiac muscle.
Conclusion
The study suggests that membrane proteoglycans play a role in the events triggered by diabetes affecting cardiac and skeletal muscles.
Supporting Evidence
- Diabetes induction by STZ injection is a well-characterized model of experimental Type 1 diabetes.
- Echocardiography showed diastolic dysfunction with altered indices in diabetic rats.
- Cardiac glypican-1 mRNA and skeletal syndecan-4 mRNA levels increased in the STZ 30-day group.
- Immunohistochemistry confirmed the increase in glypican-1 in cardiac muscle after diabetes induction.
Takeaway
The study looked at how diabetes affects heart function and certain proteins in the heart and muscles of rats, finding that these proteins change when diabetes is present.
Methodology
Diabetes was induced in male Wistar rats by STZ administration, and echocardiography, Western and Northern blots, and immunohistochemistry were used to analyze heart function and proteoglycan expression.
Limitations
The small number of animals investigated must be registered as a limitation of this study.
Participant Demographics
Male Wistar rats, weighing 200-300 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website